Premium Industrial News

China's mRNA Vaccine Market Remains in Infancy

China's mRNA Vaccine Market Remains in Infancy

pharmaceutical

Industry Segment: Pharmaceutical & Biotech | Word Count: 227 Words
Attachment: China vaccines 0721

BEIJING--July 27, 2021--Researched by Industrial Info Resources (Sugar Land, Texas)--Only 15 types of messenger RNA (mRNA) vaccines are being researched worldwide. Three of the companies involved--CuerVac, Moderna and BioNTech--are considered giants within the market. Although eight of China's pharmaceutical companies are concentrating on mRNA vaccines, all remain in the beginning stages. No licensed mRNA vaccine is yet on Chinese market.

This Premium Article can be purchased individually or as part of a subscription

Subscribe Now!(All Fields Required)

Subscription Type:

  • Pay-Per-Article - $5.95
  • Annual Premium News Subscription - $365.00
Pricing Help?